Adam Maeder
Stock Analyst at Piper Sandler
(3.87)
# 731
Out of 4,496 analysts
88
Total ratings
50.77%
Success rate
9.85%
Average return
Main Sectors:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Overweight | $490 → $495 | $455.01 | +8.79% | 13 | Jul 19, 2024 | |
| M Macy's | Maintains: Hold | $20 → $21 | $16.37 | +28.28% | 2 | May 22, 2024 | |
| NVRO Nevro | Maintains: Underweight | $15 → $12 | $9.10 | +31.87% | 12 | May 8, 2024 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $250 → $255 | $143.74 | +77.40% | 11 | May 8, 2024 | |
| SILK Silk Road Medical | Maintains: Neutral | $18 → $20 | $27.07 | -26.12% | 6 | May 1, 2024 | |
| NARI Inari Medical | Maintains: Neutral | $55 → $50 | $54.90 | -8.93% | 4 | May 1, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $85 → $88 | $86.50 | +1.73% | 10 | Apr 26, 2024 | |
| STIM Neuronetics | Reiterates: Overweight | $7 → $8 | $1.93 | +315.58% | 1 | Mar 6, 2024 | |
| NYXH Nyxoah | Maintains: Overweight | $15 → $20 | $9.10 | +119.78% | 8 | Mar 6, 2024 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $45 → $30 | $7.85 | +282.17% | 4 | Mar 5, 2024 | |
| AXNX Axonics | Downgrades: Neutral | $75 → $71 | $67.72 | +4.84% | 6 | Jan 12, 2024 | |
| NSPR InspireMD | Maintains: Overweight | $3.5 → $4.5 | $2.36 | +90.68% | 2 | Nov 2, 2023 | |
| TCMD Tactile Systems Technology | Maintains: Overweight | $25 → $30 | $12.38 | +142.33% | 2 | May 9, 2023 | |
| STXS Stereotaxis | Maintains: Overweight | $6 → $5 | $1.98 | +152.53% | 2 | Mar 6, 2023 | |
| ZYXI Zynex | Upgrades: Overweight | $10 → $18 | $10.10 | +78.22% | 2 | Jan 6, 2023 | |
| LIVN LivaNova | Maintains: Overweight | $104 → $99 | $52.91 | +87.11% | 3 | May 5, 2022 |
Intuitive Surgical
Jul 19, 2024
Maintains: Overweight
Price Target: $490 → $495
Current: $455.01
Upside: +8.79%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $16.37
Upside: +28.28%
Nevro
May 8, 2024
Maintains: Underweight
Price Target: $15 → $12
Current: $9.10
Upside: +31.87%
Inspire Medical Systems
May 8, 2024
Maintains: Overweight
Price Target: $250 → $255
Current: $143.74
Upside: +77.40%
Silk Road Medical
May 1, 2024
Maintains: Neutral
Price Target: $18 → $20
Current: $27.07
Upside: -26.12%
Inari Medical
May 1, 2024
Maintains: Neutral
Price Target: $55 → $50
Current: $54.90
Upside: -8.93%
Edwards Lifesciences
Apr 26, 2024
Maintains: Neutral
Price Target: $85 → $88
Current: $86.50
Upside: +1.73%
Neuronetics
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.93
Upside: +315.58%
Nyxoah
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $9.10
Upside: +119.78%
Vicarious Surgical
Mar 5, 2024
Maintains: Neutral
Price Target: $45 → $30
Current: $7.85
Upside: +282.17%
Axonics
Jan 12, 2024
Downgrades: Neutral
Price Target: $75 → $71
Current: $67.72
Upside: +4.84%
InspireMD
Nov 2, 2023
Maintains: Overweight
Price Target: $3.5 → $4.5
Current: $2.36
Upside: +90.68%
Tactile Systems Technology
May 9, 2023
Maintains: Overweight
Price Target: $25 → $30
Current: $12.38
Upside: +142.33%
Stereotaxis
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $1.98
Upside: +152.53%
Zynex
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $10.10
Upside: +78.22%
LivaNova
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $52.91
Upside: +87.11%